Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Whole brain mouse light sheet brain imaging service

Active
75N98026Q00887LIFECANVASTECHNOLOGIESINCFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

N/A

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(1)

Statement+of+Work+SOW+-+LifeCanvas+Technologies+Laboratory+Testing+Services.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhasePresolicitation
Posted

Presolicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA
Contacts
Vishnuvajjala Hanumanth Rao

Full Description

Show more

The imaging service will be used to analyze changes in whole brain activity from genetically modified mouse lines maintained by the Section on Neural Circuits at the NIAAA, NIH. Accurate imaging of brain activity is essential it forms the foundation for all downstream experimental analyses. Without this information, we cannot proceed with our experiments, as the validity of our data depends on the ability to quantify phenotypic differences based on genotype.



Rapid turnaround is also critical, as some experiments are age-sensitive and require genotyping results within 1 month of sample receipt. The brain tissue samples to be processed by clearing and light sheet imaging will be collected by the Lead Project Manager (LPM), and trainees in the Section on Neural Circuits at the NIAAA.



Whole brains are shipped to the company in tubes. The company processes the samples by clearing the tissue and performing light-sheet imaging. The brain is segmented into over 820 regions, and CVF files containing both raw counts and counts per area are provided. Results must be delivered within one month of sample arrival. Data are shipped to us on an NIH-supplied hard drive, and both the results and brain samples are retained by the company for at least one year to allow for any necessary retesting.



The following tasks are required to fulfill this requirement:


Receive and log incoming brain samples.


Perform tissue clearing and prepare samples for imaging.


Conduct whole-brain light-sheet imaging.


Segment the brain into defined anatomical regions (>820 areas).


Generate CVF files with raw and normalized cell counts.


Transfer data to an NIH-provided hard drive and ship to the research team.


Maintain archived data and physical samples for a minimum of one year.


More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541714
New
Federal
Combines Synopsis Solicitation- iPSC DifferentiatiThe National Institutes of Health, through its Office of the Director and Office of Acquisitions, is seeking to award a firm fixed-price contract on a non-competitive basis to Oxford StemTech Ltd of Oxford, UK, for scientific support services related to the quality control of induced pluripotent stem cells and the generation and characterization of organoids using a subset of these cell lines. This acquisition is conducted under streamlined commercial item procedures outlined in FAR Subpart 12.6 and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603, 41 U.S.C. 1901, and FAR 6.302-3(a)(2)(ii). The solicitation, identified by number 75N98026Q00878, serves as both the notice of intent and the sole solicitation document, eliminating the need for a separate formal request. The contract is classified under NAICS code 541714 and is being procured without competition due to the unique technical capabilities required and the specialized nature of the services. The response deadline for proposals is July 31, 2026, at 6:00 p.m. Eastern Time, with the posting date listed as July 27, 2026. All submissions must be directed to the designated point of contact, John R. Johnson, reachable via email at johnsonjr@mail.nih.gov, with the contract performance to be carried out in Bethesda, Maryland. The contract will be executed under the authority of the Department of Health and Human Services, and no set-asides or small business preferences are applicable. The offering entity, Oxford StemTech Ltd, has been identified as the only qualified source capable of delivering the required services, justifying the non-competitive approach under the specified regulatory exceptions.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 811210
New
Federal
Combines Synopsis Solicitation- Maintenance AgreemThe National Institutes of Health, through the Office of the Director’s Office of Acquisitions, is issuing a non-competitive combined synopsis and solicitation to award a firm fixed-price contract to Hamamatsu for the maintenance, service, and warranty support of NanoZoomer Whole Slide Image Scanners used in NIH laboratories. This acquisition is conducted under FAR Subpart 12.6 and utilizes streamlined procedures for commercial items, with no expectation of exceeding the simplified acquisition threshold. The solicitation does not seek competitive bids and is authorized under FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901, allowing for direct award to Hamamatsu based on its unique capability to service this specific equipment. The contract will provide ongoing technical expertise and comprehensive service agreements to ensure uninterrupted operation of the NanoZoomer scanners across NIH facilities. The solicitation number is 75N98026Q00883, and proposals must be submitted by July 31, 2026, at 6:00 p.m. EST. The contract is being managed by the Office of Acquisitions at NIH in Bethesda, Maryland, with Johnson, John R. as the primary point of contact. Although the place of performance is unspecified, the work will support NIH laboratory operations nationwide. The North American Industry Classification System code for this acquisition is 811210, indicating it falls under office machinery and equipment repair and maintenance. There is no set-aside type, and the entire process is designed for expedited non-competitive award based on the singular technical expertise required to maintain the proprietary NanoZoomer scanner systems.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 541713
New
Federal
Oxford Nanopore Technologies promethION 2 integrated long-read sequencerThe contract is for the procurement of an Oxford Nanopore Technologies PromethION 2 integrated long-read sequencer, a next-generation sequencing platform designed to deliver highly informative, real-time genomic and transcriptomic data. Unlike conventional next-generation sequencing technologies, this instrument enables simultaneous whole genome and transcriptome sequencing while detecting base modifications, facilitating unified multi-omics analysis with unprecedented depth and speed. The system is intended for high-impact research applications requiring comprehensive molecular profiling and real-time data integration, positioning it as a critical tool for advanced biological discovery. The solicitation, numbered 75N98026Q00877, was posted by the National Institutes of Health under the Department of Health and Human Services, with the contracting office located in Bethesda, Maryland. The opportunity is classified as a presolicitation with no set-aside designation, and it falls under NAICS code 541713 for research and development in the physical, engineering, and life sciences. The primary point of contact is Vishnuvajjala Hanumanth Rao, reachable via email at vishnuh@mail.nih.gov. Responses are due by August 5, 2026, and performance will be carried out at the agency’s facility in Bethesda, with all equipment to be deployed at the specified location.
Research and Development in Nanotechnology

POSTED

1 day ago

DEADLINE

in 8 days
View Details
NAICS: 325413
New
Federal
Combined Synopsis Solicitation- Acquire 32-sample The National Institutes of Health, through the Department of Health and Human Services, is soliciting proposals under a non-competitive combined synopsis and solicitation for the acquisition of a 32-sample product, identified by solicitation number 75N98026Q00881. This procurement is conducted under FAR Part 12.603 as a streamlined process for commercial items and falls below the simplified acquisition threshold, utilizing statutory authority under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii) to justify the absence of full and open competition. The solicitation is issued as a Notice of Intent and serves as the only formal request for proposals, with no additional written solicitation to follow. Proposals must be submitted by the deadline of August 3, 2026, at 6:00 p.m. Eastern Time, following the posting date of July 27, 2026. The contracting activity is managed by the Office of Acquisition and Logistics Operations in Bethesda, Maryland, with the NAICS code 325413 indicating the product relates to pharmaceutical and medicine manufacturing. The primary point of contact for inquiries is Cassie M. Runner, reachable via email at cassie.runner@nih.gov or phone at 301-480-8827. The place of performance has not been specified, but the contract award will be directed toward a commercial supplier capable of meeting requirements without competitive bidding, in alignment with the streamlined procedures and statutory exceptions under federal acquisition regulations. All responses must comply with the terms outlined in the combined synopsis, and no further documentation will be issued beyond this notice.
In-Vitro Diagnostic Substance Manufacturing

POSTED

1 day ago

DEADLINE

in 6 days
View Details